share_log

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt

Telomir Pharmaceuticals | 3:首次持股聲明-董事 Whalen Matthew Pratt
美股SEC公告 ·  08/15 11:22
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息